VSY Biotechnology BV, a progressive and innovative company, announced that the German Court has granted a preliminary injunction in favour of the company and against Carl Zeiss Meditec AG (Zeiss), in the action brought by VSY Biotechnology BV, against Zeiss, with allegation that it had provided misleading information to the public.

Dr. Ercan Varlibas, the chief executive officer of VSY Biotechnology, who made a statement on the matter, stated that this ruling was a victory for VSY Biotechnology, and said that large companies and their directors needed to act ethically and not give misleading information to doctors and consumers.

Dr. Varlibas, who added that they would continue to take similar legal actions against the Zeiss, in the event that it continued its unethical behaviour, stated that no one would be able to stop their fast growth and development with unethical actions.

Dr. Varlibas said, “VSY Biotechnology, the head office of which is in Amsterdam, is a young, dynamic and innovative company. It operates in 55 countries, with 270 employees. Within the next 10 years it aims to become one of the top 5 companies in the world in the field of ophthalmology. It is continuing its work in order to achieve this objective. It is planning to release 32 new ophthalmic products, which are being developed in its R&D centre, on to the market within the next 4 years.”

VSY Biotechnology has Intra Ocular Lens manufacturing facilities, which possess the Lathe cut and moulding technology. In addition to this, it also has a viscoelastic manufacturing plant and a cartridge injector manufacturing plant. VSY Biotechnology is also preparing to put its ophthalmic medicine facility into operation in 2018. According to Market Scope 2017 IOL Report, which is published by Market Scope LLC a well reputed independent research company, VSY Biotechnology BV is ranked 13th among 75 worldwide IOL manufacturers.

VSY Biotechnology is a progressive and innovative company that focuses on customer satisfaction by creating superior state of the art ophthalmology products designed and manufactured to greatly enhance and improve vision for wide range of patients around the globe.